Perspectives and Insights
Why Investors Need to Do More Rigorous Medical Diligence as a Core Part of any Healthtech Investment
Yesterday's big news, reported by Chrissy Farr of CNBC, was '“Gut health start-up uBiome files for bankruptcy five...
The Formula for Widespread Adoption of Health Products that Every Investor and Health Tech Entrepreneur Needs to Know.
Building a health product or service that will gain widespread adoption requires a long term plan and thoughtful...
Why medical diligence is essential for healthtech
We spent the early part of our careers working in the traditional health and life sciences industries. That’s where we...